A Study of the Pharmacokinetics and Safety of a Single Dose of Lenabasum in Subjects with Hepatic Impairment Compared with Matched Healthy Controls

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2020
This article has no abstract
Epistemonikos ID: 9894d2c25bde0528647091ab281ea8d3fc0a8603
First added on: Mar 18, 2025